(Q38432539)

3 September 2017

title

The needle in the haystack: application of breast fine-needle aspirate samples to quantitative protein microarray technology (English)

1 reference

3 September 2017

9

Lance A Liotta

1 reference

3 September 2017

Amy Rapkiewicz

1

1 reference

3 September 2017

Virginia Espina

2

1 reference

3 September 2017

Jo Anne Zujewski

3

1 reference

3 September 2017

Peter F Lebowitz

4

1 reference

3 September 2017

Armando Filie

5

1 reference

3 September 2017

Julia Wulfkuhle

6

1 reference

3 September 2017

Kevin Camphausen

7

1 reference

3 September 2017

Emanuel F Petricoin

8

1 reference

3 September 2017

Andrea Abati

10

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

3 September 2017

1 reference

3 September 2017

volume

111

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

173-184

1 reference

Evaluation of abnormal mammography results and palpable breast abnormalities

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

Monitoring signal transduction in cancer: tyrosine kinase gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

Gene expression profiling of lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Molecular and biologic markers of premalignant lesions of human breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

DNA microarrays in breast cancer: the promise of personalised medicine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Genomic and proteomic technologies for individualisation and improvement of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Breast fine needle aspiration biopsy: prevailing recommendations and contemporary practices

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Gene silencing: shrinking the black box of RNAi

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Protein microarrays: meeting analytical challenges for clinical applications.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Signal pathway profiling of prostate cancer using reverse phase protein arrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Protein microarrays: molecular profiling technologies for clinical specimens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Gene expression profiling of primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

The ternary complex factor Net contains two distinct elements that mediate different responses to MAP kinase signalling cascades

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Proteomics: applications and opportunities in preclinical drug development

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry: potential for diagnostic applications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Clinical applications of proteomics: proteomic pattern diagnostics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

A prototype for unsupervised analysis of tissue microarrays for cancer research and diagnostics.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Diagnostic accuracy of fine-needle aspiration biopsy is determined by physician training in sampling technique

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast?: Cytomorphologic criteria and limitations in diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

The palpable breast nodule. A cost-effectiveness analysis of alternate diagnostic approaches

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Akt-regulated pathways in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

PTEN: The down side of PI 3-kinase signalling.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Array-based multiplexed screening and quantitation of human cytokines and chemokines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Breast cancer--loss of PTEN predicts resistance to treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Integrating proteomic and functional genomic technologies in discovery-driven translational breast cancer research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22686

7 January 2021

Identifiers

DOI

10.1002/CNCR.22686

1 reference

3 September 2017

1 reference